Browsing by Author "Solomon, Benjamin"
Now showing items 1-5 of 5
-
A WIN Consortium phase I study exploring avelumab, palbociclib, and axitinib in advanced non-small cell lung cancer
Callejo Perez, Ana; Bar, Jair; Berchem, Guy; Bazhenova, Lyudmila; Saintigny, Pierre; Felip Font, Enriqueta; Solomon, Benjamin (Wiley, 2022-07) -
Intracranial and extracranial efficacy of lorlatinib in patients with ALK-positive non-small-cell lung cancer previously treated with second-generation ALK TKIs
Felip Font, Enriqueta; Shaw, Alice Tsang; Bearz, A.; Camidge, D. R.; Bauman, J. R.; Solomon, Benjamin (Elsevier, 2021-05) -
Patient-reported outcomes from the randomized phase 3 CROWN study of first-line lorlatinib versus crizotinib in advanced ALK-positive non-small cell lung cancer
Iadeluca, Laura; Shaw, Alice Tsang; de Marinis, Filippo; Felip Font, Enriqueta; Solomon, Benjamin; Bauer, Todd; Mazieres, Julien (Elsevier, 2022-12) -
Plain language summary of the updated results from the CROWN study comparing lorlatinib with crizotinib in people with advanced non-small-cell lung cancer
Solomon, Benjamin; Bauer, Todd; Mok, Tony; Liu, Geoffrey; MAZIERES, JULIEN; de Marinis, Filippo; FELIP, ENRIQUETA (Future Medicine, 2023-05) -
Selpercatinib in Patients With RET Fusion–Positive Non–Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial
Drilon, Alexander; Gautschi, Oliver; Tomasini, Pascale; de Braud, Filippo G.; Alonso-Casal, Guzman; Solomon, Benjamin; Subbiah, Vivek (American Society of Clinical Oncology, 2023-01-10)